Samumed
Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a private biopharmaceutical company based in San Diego, San Diego, California. It was founded in 2008 by Osman Kibar."Forbes Profile: Osman Kibar"
"Forbes" Samumed's products in development target novel components of the Wnt signaling pathway.Herper, Matthe
"Cure Baldness? Heal Arthritis? Erase Wrinkles? An Unknown Billionaire's Quest To Reverse Aging"
"Forbes", May 10, 2016Ramsey, Lydia

[...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]  

Osman Kibar
Osman Kibar (born 1971) is a Turkish American billionaire. He is the founder of the biotechnology firm Biosplice. Early life and education Kibar was born in 1971 in İzmir, Turkey, as the grandson of , who was the mayor of İzmir from 1964 to 1973. His father, Seli Kibar, was an economist. He attended İzmir Gazipaşa Primary School and then Robert College. For college, he moved to the United States to attend a 3-2 program, studying economics at Pomona College and electrical engineering at Caltech, and receiving a bachelor degree from both. He did his masters and doctorate on biophotonics at UC San Diego. Career In the late 1990s, when he was finishing his doctorate, he invented a cancer diagnosis system, which he turned into a company called Genoptix. The company went public a few years later, and was purchased by Novartis in 2011 for $476 million. After completing his education, Kibar moved to New York City, where he worked for the hedge fund sponsor Pequot Ca ...
[...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]